RASSF1 and cancer: The failure of DETA/NO to show growth inhibitory effects on RASSF1 or CDKN1 knockdown endometrial cancer cells alludes to the critical role of RASSF1 or CDKN1 in the DETA/NO-induced growth inhibition of cancer.